Singapore Institute of Food and Biotechnology Innovation (SIFBI)
In April 2020, the Singapore Institute of Food and Biotechnology Innovation (SIFBI) was established with the aim of bringing cutting edge biotechnology in the forefront to drive innovation in food and many other applications. The institute pulls together research capabilities in areas such as food, nutrition, public health, biotechnology, manufacturing, agri-food technology, and safety research under one roof.
These capabilities will support the development of solutions for the needs of the Asian market, such as the discovery and production of health and sustainable foods. It also accelerates the transformation of the food industry, capturing new opportunities in established industries such as advanced manufacturing, specialty chemicals, biopharmaceuticals, and food manufacturing.
- Shared Analytics Platform
Singapore Immunology Network (SIgN)
The Singapore Immunology Network (SIgN) was initiated in December 2005 with the aim of expanding and strengthening immunology research capabilities in Singapore to support efficient translation into clinical applications in areas of medical needs. In January 2008, 6000m2 of new laboratory and office space was inaugurated as the home of SIgN, in the Immunos building at Biopolis. Human Immunology will be the focus of SIgN. Researchers at SIgN investigate immunity during infections and inflammatory conditions, including cancer, by using animal models to complement patient cohort studies, in an effort to translate bench discoveries into bedside medical treatments. Our Scientists' work is supported by cutting edge technological research platforms and core services. SIgN was also designed to attract and link up with companies in the biomedical field, feeding their pipelines with novel discoveries, in order to create a positive impact on Singapore’s economy. Since its establishment, SIgN has delivered outstanding scientific output that gained international recognition for Singapore’s Biomedical Sciences.Research Capabilities
Skin Research Institute of Singapore (SRIS)
The Skin Research Institute of Singapore (SRIS), a collaboration between A*STAR, the National Healthcare Group, which comprises the National Skin Centre, and the Nanyang Technological University (NTU) was set up in 2013 to conduct research on skin and hair conditions prevalent in Asia and the tropics. SRIS is the largest skin research institute in the world, with over 200 researchers. It harnesses the expertise of scientists, clinicians and engineers in a unique, multi-disciplinary approach to skin and hair research to improve the well-being and health of consumers and patients alike.
The key research programmes at SRIS include:
- Atopic Dermatitis
- Acne & Sebaceous Gland
- Asian Skin Microbiome
- Wound Care
- Skin Ageing and Pigmentation